Safety and Tolerability of Levomilnacipran ER in Major Depressive Disorder: Results from an Open-Label, 48-Week Extension Study.

Autor: Mago, Rajnish1 rajnish.mago@jefferson.edu, Forero, Giovanna2, Greenberg, William2, Gommoll, Carl2, Chen, Changzheng3
Zdroj: Clinical Drug Investigation. Oct2013, Vol. 33 Issue 10, p761-771. 11p.
Databáze: Academic Search Ultimate